Sterigenics, a Subsidiary of Sotera Health Co., Reaches $34 Million Settlement in Willowbrook EO Claims
Sterigenics U.S., LLC, a subsidiary of Sotera Health Company, has reached a binding term sheet agreement to resolve 129 ethylene oxide claims related to its former facility in Willowbrook, Illinois. The settlement includes ten claims set for trials in the Circuit Court of Cook County in 2025 and 2026, as well as other claims from an additional 119 claimants. As part of the agreement, Sterigenics will pay $34 million, and the plaintiffs' claims will be dismissed with prejudice. The settlement process is anticipated to take 60 to 90 days and requires several conditions to be met, including full claimant participation and a good faith determination by the court. Sterigenics denies any liability, and the settlement is not to be interpreted as an admission of safety hazards from the facility's emissions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sotera Health Co. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001822479-25-000036), on July 24, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。